Infant gut microbiota and functional foods: Opportunities for early health intervention

The infant gut microbiome, established at birth, plays a critical role in immune, metabolic, and neurological development. Early-life exposures, including delivery mode and feeding practices, significantly influence microbial colonization. This review aims to evaluate how functional foods, including probiotics, prebiotics, synbiotics, and human milk oligosaccharides (HMOs), modulate the infant gut microbiota during this critical developmental window and their implications for long-term health.

We synthesized findings from clinical trials, systematic reviews, and mechanistic studies exploring the role of functional food components in shaping infant microbiota composition and functionality. The review integrates insights from microbiology, immunology, and nutrition science, with emphasis on interventions during infancy.

Breastfeeding and HMOs promote Bifidobacterium dominance, linked to reduced risks of allergies, obesity, and inflammatory bowel disease. HMO-supplemented formulas approximate the microbial profiles of breastfed infants, and probiotics, such as Lactobacillus rhamnosus GG, reduce the incidence of atopic dermatitis. Synbiotics enhance gut health in preterm infants, thereby reducing morbidity. Despite the demonstrated benefits, challenges persist in probiotic stability, host-specific responses, and regulatory harmonization.

Functional foods offer a promising, evidence-based strategy to harness early microbial plasticity and promote resilience against chronic disease. Standardized formulations, longitudinal studies, and personalized approaches are needed to optimize their implementation in diverse infant populations.